LONDON-Covington advised Draig Therapeutics Limited on its $140m financing since inception of the company in 2024.
Draig Therapeutics is developing novel treatment options for neuropsychiatric disorders and was co-founded by Cardiff University and SV Health Investors, which led the seed financing with ICG. The oversubscribed Series A financing was led by Access Biotechnology, with participation from Canaan Partners, SR One, Sanofi Ventures, Schroders Capital along with seed investors.
The Covington team was led by Ben Land-Maycock and Katy Knight.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.